Emerging Infectious Disease ISSN: 1080-6059

Epidemiology of Human T-cell Lymphotropic Virus Type 1 Infection in Blood Donors, Israel

Shmuel Stienlauf¹

, Vered Yahalom¹, Eli Schwartz, Eilat Shinar, Gad Segal, and Yechezkel Sidi

Author affiliations: Sheba Medical Center, Tel Hashomer, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Tel Aviv University, Tel Aviv, Israel (S. Stienlauf, E. Schwartz, G. Segal, Y. Sidi); Magen David Adom National Blood Services, Ramat Gan, Israel (V. Yahalom, E. Shinar).; 1These authors contributed equally to this article.

Main Article

Figure 2

Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.

Figure 2. . Relative risk for human T-cell lymphotropic virus type 1 carriage in donors from different geographic origins. Odds ratios (indicated by black boxes) are charted in logarithmic scale. Error bars indicate 95% confidence intervals (CI). *Per 100,000 population; †p<0.05.

Main Article

¹These authors contributed equally to this article.

Top of Page

The opinions expressed by authors contributing to this journal do not necessarily reflect the opinions of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.